These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9727728)

  • 21. Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze.
    Sela VR; Roncon CM; Zangrossi H; Graeff FG; Audi EA
    Life Sci; 2010 Sep; 87(13-14):445-50. PubMed ID: 20816996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R; Thomas P; Dupuis B
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency.
    Tome MB; Isaac MT; Harte R; Holland C
    Int Clin Psychopharmacol; 1997 Mar; 12(2):81-9. PubMed ID: 9219043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective serotonin reuptake inhibitors plus pindolol.
    Isaac MT; Tome MB
    Lancet; 1997 Jul; 350(9073):288-9. PubMed ID: 9242815
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
    J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.
    Landén M; Björling G; Agren H; Fahlén T
    J Clin Psychiatry; 1998 Dec; 59(12):664-8. PubMed ID: 9921700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
    Serrano-Blanco A; Pinto-Meza A; Suárez D; Peñarrubia MT; Haro JM;
    Acta Psychiatr Scand Suppl; 2006; (432):39-47. PubMed ID: 17087814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
    Russell JM; Berndt ER; Miceli R; Colucci S; Grudzinski AN
    Am J Manag Care; 1999 May; 5(5):597-606. PubMed ID: 10537866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
    Liu Y; Zhou X; Zhu D; Chen J; Qin B; Zhang Y; Wang X; Yang D; Meng H; Luo Q; Xie P
    Hum Psychopharmacol; 2015 May; 30(3):132-42. PubMed ID: 25689398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.
    Martiny K; Lunde M; Bech P; Plenge P
    Nord J Psychiatry; 2012 Jun; 66(3):147-54. PubMed ID: 22458638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
    Hamer AM; Hartung DM; Haxby DG; Ketchum KL; Pollack DA
    J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily high-dose pindolol for SSRI-refractory depression.
    Sokolski KN; Conney JC; Brown BJ; DeMet EM
    Psychiatry Res; 2004 Feb; 125(2):81-6. PubMed ID: 15006431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol.
    Gruwez B; Dauphin A; Tod M
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):663-83. PubMed ID: 16307210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.
    Stein MB; Sareen J; Hami S; Chao J
    Am J Psychiatry; 2001 Oct; 158(10):1725-7. PubMed ID: 11579011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.
    Panzer PE; Regan TS; Chiao E; Sarnes MW
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S370-9. PubMed ID: 16236019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.
    Ostroff RB; Nelson JC
    J Clin Psychiatry; 1999 Apr; 60(4):256-9. PubMed ID: 10221288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective serotonin reuptake inhibitors plus pindolol. The REEP.
    Bordet R; Thomas P; Dupuis B
    Lancet; 1997 Jul; 350(9073):289. PubMed ID: 9242816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.